The unique and specialized skills and competencies in vascular disease management and intervention have evolved rapidly over the past decade and now define and require a separate specialty. However, this evolutionary process has met with hostile opposition and rejection from The American Board of Surgery (ABS).
The managed care industry is dominated by fewer that 10 large health plans. The majority of HMOs and PPOs are in the "middle" while there are 300 plans with fewer than 20,000 members each.
Ultra-Screen is a revolutionary new first trimester screening test for Down Syndrome that is available to pregnant women of all ages between 11-14 weeks of pregnancy. The test combines a blood test with an ultrasound measurement, and in clinical research Ultra-Screen detected over 85-93% of babies with Down syndrome and T-18, with a false positive rate of five percent.